Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A modular system for murine CRISPR genome and epigenome editing

Award Number: R21OD037909
ORGANIZATION: OFFICE OF THE DIRECTOR, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/15/2025
PERIOD OF PERFORMANCE END DATE: 03/31/2027

Group Awards By:

View Award Description

A modular system for murine CRISPR genome and epigenome editing - Project Summary RNA-guided DNA sequence recognition by CRISPR/Cas9 has been exploited to develop an array of genome and epigenome editors, including base editors, primer editors, CRISPR-activators (CRISPR-a) and CRISPR-interference (CRISPR-i). These editors consist of either nuclease dead (dCas9) or DNA-nickase (nCas9) variants of Cas9 fused at N and C termini to “accessory protein” which contain the editor-specific activity. The enzymatic activities of these accessory proteins are being evolved very rapidly to increase the accuracy, efficiency, and types of editing possible. Mice harboring these editors as transgenes are invaluable research tools. However, generating mice containing transgenes that express the latest suite of Cas9 editors is challenging, given their rapid rate of change and ever-increasing number. These editors can be delivered using adeno-associated virus (AAV) vectors, but due to packaging limits of AAV most require a dual AAV strategy involving intein-mediated protein splicing, which hampers editing efficiency and homogeneity. Here we propose to generate mouse lines that express the core dCas9 or nCas9 RNA-guided DNA sequence recognition platforms, functionalized at N- and C-termini with protein ligation tags. The accessory proteins and guide RNAs will be introduced using single AAV vectors. This combination will achieve higher level and more homogeneous editing than possible with AAV-only strategies, while retaining flexibility and the ability to exploit the latest advances in editor enzyme engineering. In Aim 1, we will create Cre-triggered mouse/AAV systems for CRISPR-i/a. We will create mice with Cre-activated expression of dCas9 with N- and C-terminal protein ligation tags, which will efficiently join to AAV-delivered N- or C-terminal epigenetic editors to implement CRISPR-i/a. In Aim 2, we will create Cre-triggered mouse/AAV systems for base and prime editing. We will create mice with Cre-activated expression of nCas9T (nicks the target strand) with N- and C-terminal protein ligation tags, which will efficiently join to AAV-delivered N- or C-terminal base editors. We will further create mice with Cre- activated expression of nCas9NT (nicks the non-target strand) with N- and C-terminal protein ligation tags, which will efficiently join to AAV-delivered reverse transcriptase. These mouse/AAV systems will be invaluable reagents to probe disease biology, perform proof-of-concept therapeutic gene editing, and enable efficient in vivo CRISPR screens using genome or epigenome editing. This proposal is responsive to PAR-21-167. Development of Animal Models and Related Biological Materials for Research.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $202,920 )
2026	2026	CHILDREN'S HOSPITAL CORPORATION, THE	300 LONGWOOD AVE	BOSTON	MA	02115	SUFFOLK	USA	Research Infrastructure Programs	000	2	3/27/2026	NON-COMPETING CONTINUATION	$202,920
														Subtotal = $202,920

Issue Date FY: 2025 ( Subtotal = $222,500 )
2025	2025	CHILDREN'S HOSPITAL CORPORATION, THE	300 LONGWOOD AVE	BOSTON	MA	02115	SUFFOLK	USA	Research Infrastructure Programs	000	1	5/8/2025	NEW	$222,500
														Subtotal = $222,500

Grand Total All Awards = $425,420

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A modular system for murine CRISPR genome and epigenome editing

Award Number: R21OD037909

ORGANIZATION: OFFICE OF THE DIRECTOR, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/15/2025

PERIOD OF PERFORMANCE END DATE: 03/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer